Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Active, Not Recruiting

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

NCT01817192

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Leonard Cancer Institute Mission Viejo, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Providence Medical Foundation Santa Rosa Santa Rosa, California, United States
  • Sarah Cannon- FCS South Fort Meyers, Florida, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

NCT03944772

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Santa Monica, California, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

A Study of AL8326 in Non-Small Cell Lung Cancer

NCT06794957

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Bengbu Medicaal University Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Xuancheng People´s Hospital Xuancheng, Anhui, China
  • Anyang Cancer Hospital Anyang, Henan, China
View Trial Details
Active, Not Recruiting

Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)

NCT05712902

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital，Capital Medical University Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View all 33 locations
View Trial Details
Active, Not Recruiting

Tumor-specific T Cells in Lung Cancer

NCT02515760

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Division of Thoracic Surgery, Technical University of Munich, Munich, Germany Munich, Germany
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

NCT03425643

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0028) Gilbert, Arizona, United States
  • Western Regional Medical Center, Inc. ( Site 0050) Goodyear, Arizona, United States
  • University of Arizona Cancer Center - Dignity Health ( Site 0062) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0012) Tucson, Arizona, United States
View all 227 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • St. Bernards Medical Center ( Site 0103) Jonesboro, Arkansas, United States
  • St Joseph Heritage Healthcare-Oncology ( Site 0102) Fullerton, California, United States
  • Cancer Blood and Specialty Clinic ( Site 0105) Los Alamitos, California, United States
  • PIH Health Hematology Medical Oncology ( Site 0106) Whittier, California, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

A Study of NDI 1150-101 in Patients With Solid Tumors

NCT05128487

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 19 locations
View Trial Details

Related conditions